✦ LIBER ✦

Clinical Staging and the Tendency of Malignant Pleural Mesotheliomas to Remain Localized

✍ Scribed by Nauta, Russell J.; Osteen, Robert T.; Antman, Karen H.; Koster, J. Kenneth

Book ID: 123165075
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 357 KB
Volume: 34
Category: Article
ISSN: 0003-4975
DOI: 10.1016/S0003-4975(10)60855-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Staging and response to therapy of malig

Staging and response to therapy of malignant pleural mesothelioma

✍ Heelan, Robert 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Imaging evaluation in the diagnosis and

Imaging evaluation in the diagnosis and staging of malignant pleural mesothelioma

✍ Mylene T Truong; Jeremy J Erasmus; Edith M Marom; Reginald F Munden 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 673 KB

Evaluation of the clinical TNM staging s

Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients

✍ Tammilehto, L.; Kivisaari, L.; Salminen, U.-S.; Maasilta, P.; Mattson, K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 530 KB

165P CLINICAL AND EPIDEMIOLOGICAL APPROA

165P CLINICAL AND EPIDEMIOLOGICAL APPROACH TO THE MALIGNANT PLEURAL MESOTHELIOMA IN THE REGION OF ORAN

✍ Ziane, B.; Rezk-kallah, B.; Berrabah, Y.; Tebboune, B. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Extra-pleural pneumonectomy versus no ex

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

✍ Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; Jame 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 342 KB

The use of histological and immunohistoc

The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma andin situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis

✍ Cury, P. M.; Butcher, D. N.; Corrin, B.; Nicholson, A. G. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Distinguishing malignant mesothelioma from reactive mesothelial hyperplasia and reactive fibrosis can be a diagnostic problem in small pleural biopsies, made more difficult by the recent recognition of mesothelioma-in-situ. Antibodies to epithelial membrane antigen (EMA), p53, and bcl-2 have all bee